World Health Organization Raises Warning Over Severe Scarcity of Obesity Medications
Less than 10% of people who could benefit from weight-loss injections like Wegovy can access them, states the WHO as it publishes its initial recommendations on the therapies.
Given in excess of 1,000,000,000 people worldwide currently classified as obese, it is urging more widespread and fairer access to GLP-1 medication.
According to projections, in excess of 2,000,000,000 could be obese by 2030 unless action is taken.
"The new guidance recognises that excess weight is a chronic disease that can be treated with comprehensive and continuous support," remarked its chief Tedros Adhanom Ghebreyesus.
Significant expense, constrained manufacturing, and logistical bottlenecks are significant hurdles to broad access to the injections that can assist patients in reducing considerable body mass, explains the organization.
Skinny Jab Shortage
Even in the present best projected case, the production of such drugs could only cover approximately 100 million people – less than 10% of eligible patients, as stated by the WHO.
The guideline calls on countries and companies to expand access, through strategies like patent sharing.
Exclusive production rights on the active ingredient – the main component of a leading brand – is set to lapse in multiple nations in 2026.
The Way Obesity Jabs Function
These medications mimick a body's own hormone to slow digestion, curb appetite and increase feelings of fullness so people consume fewer calories.
People typically see weight reduction within a few weeks of commencing the weekly injections.
Research points to patients may regain a significant portion within a year of stopping the medication, when their typical hunger come back.
Being above a healthy weight increases your likelihood for developing health problems, such as diabetes, heart disease, brain attack, and specific malignancies.
Obesity affects individuals in every country and was responsible for over three and a half million deaths worldwide in 2024, per the WHO.
